Factors in Selecting Therapy for HER2+ Metastatic Breast Cancer With CNS Disease

Findings highlight a need to incorporate diverse populations when developing guideline-concordant breast cancer care to achieve efficacy for all patients.

Heather McArthur, MD, focused on current and future strategies for treating early-stage breast cancer.

Paolo Tarantino, MD, and Matteo Lambertini, MD, PhD discuss findings related to CDK4/6 inhibitors and antibody drug conjugates presented at SABCS 2024.